Currently, Houlihan Lokey Inc [HLI] is trading at $175.04, up 6.60%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HLI shares have gain 6.80% over the last week, with a monthly amount glided 23.62%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Houlihan Lokey Inc [NYSE: HLI] stock has seen the most recent analyst activity on March 13, 2025, when Morgan Stanley upgraded its rating to a Overweight and also revised its price target to $190 from $201. Previously, Wells Fargo upgraded its rating to Overweight on March 11, 2025, and dropped its price target to $179. On December 09, 2024, downgrade downgraded it’s rating to Underweight and revised its price target to $200 on the stock. Wells Fargo started tracking the stock assigning a Underweight rating and suggested a price target of $149 on September 12, 2024. Morgan Stanley upgraded its rating to Equal-Weight for this stock on July 18, 2022, and downed its price target to $82. In a note dated April 07, 2022, Piper Sandler downgraded an Underweight rating on this stock and revised its target price from $92 to $76.
This stock has fluctuated between a low of $127.14 and a high of $192.10 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $179 within the next 12 months. Houlihan Lokey Inc [NYSE: HLI] shares were valued at $175.04 at the most recent close of the market. An investor can expect a potential return of 2.26% based on the average HLI price forecast.
Analyzing the HLI fundamentals
Trailing Twelve Months sales for Houlihan Lokey Inc [NYSE:HLI] were 2.39B which represents 28.05% growth. Gross Profit Margin for this corporation currently stands at 0.29% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.22%, and Net Profit Margin reading is 0.16%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is 0.19 and Total Capital is 0.18. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 169.69 points at the first support level, and at 164.34 for the second support level. However, for the 1st resistance point, the stock is sitting at 178.67, and for the 2nd resistance point, it is at 182.30.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 5.13, the price to book ratio is 5.62 and price to earnings (TTM) ratio is 30.12.
Transactions by insiders
Recent insider trading involved Zucker Gillian Beth, Director, that happened on Apr 14 ’25 when 200.0 shares were sold. Director, GILLIAN ZUCKER completed a deal on Apr 14 ’25 to buy 200.0 shares. Meanwhile, Director Zucker Gillian Beth sold 200.0 shares on Mar 13 ’25.
